HeartBeam has developed core technology that enables a new paradigm in cardiac care. HeartBeam's developed the first ever cable-free 12-lead ECG that patients can use wherever they are. We do this by ...

Such efforts will facilitate the introduction of new wearable devices such as Smartwatches, chest straps, smart garments and patches that will collect additional monitored bio-signs and multiple ECG ...

This is the offical code repository accompanying our paper on Self-supervised representation learning from 12-lead ECG data. For a detailed description of technical details and experimental results, ...

The purpose of this study was to evaluate whether the 12-lead ECG could be substituted by ECG sets with a limited number of leads. Materials and methods: The performance of three ECG systems (ie ...

Leading the Way in ECG Technology Norav Medical is at the forefront of advancing ECG systems, offering a comprehensive range of cardiac diagnostic solutions tailored for both clinical and home use.

The database consists of 2032 10-second 12-lead ECG signal records representing different morphologies of the ECG signal. Signals are digitized at 500 samples per second. The ECGs were collected from ...

All patients had high-sensitivity troponin test results within 6 hours after 12-lead ECG. Both troponin I (TnI) and TnT were ...

SANTA CLARA, Calif., November 07, 2024 -- ( BUSINESS WIRE )-- HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company ...

Background: Electrocardiographic markers differentiating between death caused by ventricular arrhythmias and non-arrhythmic death could improve the selection of patients for implantable ...

It is notable that the ECG obtained at presentation showed the presumed sinus rhythm with first-degree atrioventricular block (PR interval, 230 milliseconds), along with right bundle-branch block and ...

Despite a net loss and cash constraints, HeartBeam Inc (BEAT) remains optimistic about FDA clearance and its groundbreaking ECG technology.